You are here
- Home
- Therapy Areas
- Oncology/Infection
A Phase I, open label study to assess the saftey and tolerability of ZD6474 (ZACTIMA) in combination with Vinorelbine (Navelbine) or Gemcitabine (Gemzar) plus cisplatin as first line therapy in patients with locally advanced or metastatic (Stage IIIB-IV) Non Small Cell Lung Cancer.
- Disease
- solid tumour
- Drug Name
- Caprelsa
- Generic Name
- vandetanib
- Sponsor
- AstraZeneca
- Drug Status
- Approved Medicine
- Phase
- I
- Start Date
- Aug 21, 2006
- Study Name
- D4200C00054
- Study Id
- D4200C00054
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
